Abeona Therapeutics
ABEO
ABEO
95 hedge funds and large institutions have $198M invested in Abeona Therapeutics in 2025 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 30 increasing their positions, 13 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
+24
Holders Change %
+33.8%
% of All Funds
1.27%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
42
Increased
30
Reduced
13
Closed
18
Calls
$14.7M
Puts
$2.43M
Net Calls
+$12.2M
Net Calls Change
+$9.57M
Top Buyers
1 |
BlackRock
New York
|
+$14.1M |
2 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
+$7.13M |
3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$5.21M |
4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.88M |
5 |
Morgan Stanley
New York
|
+$3.71M |
Top Sellers
1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$8.6M |
2 |
LCM
Laurion Capital Management
New York
|
-$5.85M |
3 |
SCM
Suvretta Capital Management
New York
|
-$5.73M |
4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.01M |
5 |
Millennium Management
New York
|
-$3.14M |